C
Central Pharmaceutical JSC No3
VN:DP3
Central Pharmaceutical JSC No3
VN:DP3
Price:
62 800
VND
-0.79%
Market Cap:
₫1.4T
Balance Sheet
Balance Sheet Decomposition
Central Pharmaceutical JSC No3
Central Pharmaceutical JSC No3
Balance Sheet Decomposition is not available for
Central Pharmaceutical JSC No3
Central Pharmaceutical JSC No3
Balance Sheet
Central Pharmaceutical JSC No3
Central Pharmaceutical JSC No3
Currency: VND
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
2 426
|
8 466
|
17 810
|
31 566
|
44 380
|
54 508
|
40 918
|
24 701
|
21 106
|
5 375
|
13 706
|
|
| Cash |
2 426
|
8 466
|
17 810
|
11 566
|
20 880
|
19 508
|
20 918
|
24 701
|
21 106
|
5 375
|
13 706
|
|
| Cash Equivalents |
0
|
0
|
0
|
20 000
|
23 500
|
35 000
|
20 000
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
105 000
|
120 000
|
137 000
|
185 378
|
301 000
|
327 987
|
|
| Total Receivables |
15 911
|
16 179
|
30 585
|
28 539
|
39 918
|
20 776
|
29 272
|
22 431
|
28 783
|
23 149
|
39 448
|
|
| Accounts Receivables |
13 709
|
12 187
|
26 320
|
20 657
|
31 676
|
15 450
|
23 940
|
20 857
|
26 898
|
17 061
|
34 817
|
|
| Other Receivables |
2 202
|
3 992
|
4 265
|
7 882
|
8 243
|
5 326
|
5 331
|
1 574
|
1 885
|
6 088
|
4 631
|
|
| Inventory |
43 517
|
54 739
|
52 777
|
67 883
|
59 088
|
56 087
|
56 385
|
65 613
|
69 835
|
52 332
|
43 925
|
|
| Other Current Assets |
403
|
881
|
390
|
470
|
909
|
6 021
|
8 236
|
3 979
|
5 084
|
1 896
|
8 260
|
|
| Total Current Assets |
62 257
|
80 265
|
101 561
|
128 459
|
144 296
|
242 393
|
254 811
|
253 725
|
310 186
|
383 752
|
433 326
|
|
| PP&E Net |
88 167
|
93 471
|
87 976
|
81 280
|
89 066
|
81 487
|
142 492
|
146 135
|
140 566
|
131 247
|
119 745
|
|
| PP&E Gross |
88 167
|
93 471
|
87 976
|
81 280
|
89 066
|
81 487
|
142 492
|
146 135
|
140 566
|
131 247
|
119 745
|
|
| Accumulated Depreciation |
21 710
|
28 967
|
36 209
|
44 139
|
52 232
|
60 534
|
67 771
|
79 416
|
92 551
|
105 124
|
116 659
|
|
| Intangible Assets |
0
|
3 058
|
4 414
|
4 414
|
5 814
|
5 814
|
5 814
|
6 594
|
20 361
|
20 281
|
20 201
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1 409
|
805
|
602
|
504
|
634
|
39 487
|
38 242
|
37 338
|
36 755
|
35 346
|
34 504
|
|
| Total Assets |
151 836
N/A
|
177 598
+17%
|
194 553
+10%
|
214 656
+10%
|
239 811
+12%
|
369 181
+54%
|
441 359
+20%
|
443 792
+1%
|
507 868
+14%
|
570 626
+12%
|
607 777
+7%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
10 921
|
21 757
|
22 968
|
25 599
|
20 578
|
14 567
|
23 880
|
19 499
|
18 474
|
15 695
|
7 642
|
|
| Accrued Liabilities |
3 303
|
6 840
|
6 347
|
12 089
|
15 024
|
32 580
|
41 568
|
44 408
|
50 742
|
58 681
|
63 036
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
4 100
|
5 400
|
5 378
|
0
|
0
|
6 800
|
0
|
|
| Current Portion of Long-Term Debt |
17 329
|
24 983
|
17 912
|
8 300
|
3 200
|
3 059
|
0
|
3 528
|
5 230
|
0
|
0
|
|
| Other Current Liabilities |
3 686
|
5 459
|
7 434
|
16 555
|
12 988
|
11 888
|
24 085
|
11 485
|
15 972
|
20 004
|
18 218
|
|
| Total Current Liabilities |
35 239
|
59 039
|
54 662
|
62 542
|
55 890
|
67 494
|
94 911
|
78 920
|
90 418
|
101 179
|
88 896
|
|
| Long-Term Debt |
20 319
|
15 859
|
9 459
|
6 259
|
3 059
|
0
|
0
|
0
|
0
|
975
|
0
|
|
| Total Liabilities |
55 558
N/A
|
74 898
+35%
|
64 121
-14%
|
68 801
+7%
|
58 949
-14%
|
67 494
+14%
|
94 911
+41%
|
78 920
-17%
|
90 418
+15%
|
102 154
+13%
|
88 896
-13%
|
|
| Equity | ||||||||||||
| Common Stock |
52 500
|
52 500
|
68 000
|
68 000
|
68 000
|
86 000
|
86 000
|
86 000
|
86 000
|
214 999
|
214 999
|
|
| Retained Earnings |
12 347
|
17 710
|
29 232
|
43 564
|
76 694
|
103 606
|
144 231
|
151 249
|
194 534
|
203 333
|
241 215
|
|
| Additional Paid In Capital |
26 035
|
25 925
|
25 824
|
25 789
|
25 749
|
97 659
|
97 659
|
97 659
|
97 659
|
0
|
0
|
|
| Other Equity |
5 397
|
6 566
|
7 377
|
8 503
|
10 419
|
14 422
|
18 559
|
29 965
|
39 257
|
50 140
|
62 666
|
|
| Total Equity |
96 279
N/A
|
102 700
+7%
|
130 432
+27%
|
145 855
+12%
|
180 862
+24%
|
301 687
+67%
|
346 448
+15%
|
364 872
+5%
|
417 450
+14%
|
468 472
+12%
|
518 881
+11%
|
|
| Total Liabilities & Equity |
151 836
N/A
|
177 598
+17%
|
194 553
+10%
|
214 656
+10%
|
239 811
+12%
|
369 181
+54%
|
441 359
+20%
|
443 792
+1%
|
507 868
+14%
|
570 626
+12%
|
607 777
+7%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
6
|
6
|
7
|
7
|
7
|
9
|
22
|
22
|
22
|
21
|
21
|
|
Switch to:
Switch to:
See Also
Discover More
